B
BioNote Inc
KRX:377740
BioNote Inc
KRX:377740
Price:
5 850
KRW
0.34%
Market Closed
Market Cap:
₩597.1B
Income Statement
Earnings Waterfall
BioNote Inc
BioNote Inc
Income Statement
BioNote Inc
BioNote Inc
Currency: KRW
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
72
|
82
|
84
|
82
|
86
|
544
|
603
|
647
|
676
|
254
|
234
|
259
|
282
|
300
|
|
| Revenue |
566 953
N/A
|
546 841
-4%
|
479 657
-12%
|
224 641
-53%
|
131 976
-41%
|
91 102
-31%
|
90 081
-1%
|
94 216
+5%
|
95 081
+1%
|
99 806
+5%
|
102 780
+3%
|
105 917
+3%
|
112 044
+6%
|
115 095
+3%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(131 972)
|
(134 445)
|
(138 925)
|
(98 399)
|
(135 057)
|
(123 632)
|
(101 650)
|
(102 804)
|
(48 072)
|
(51 219)
|
(51 540)
|
(52 140)
|
(52 848)
|
(50 975)
|
|
| Gross Profit |
434 981
N/A
|
412 396
-5%
|
340 732
-17%
|
126 242
-63%
|
(3 081)
N/A
|
(32 529)
-956%
|
(11 569)
+64%
|
(8 588)
+26%
|
47 009
N/A
|
48 587
+3%
|
51 240
+5%
|
53 777
+5%
|
59 196
+10%
|
64 119
+8%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(63 403)
|
(59 926)
|
(45 322)
|
(195 524)
|
(33 922)
|
(52 795)
|
(35 472)
|
(42 671)
|
(32 494)
|
(37 068)
|
(39 025)
|
(40 340)
|
(42 074)
|
(45 711)
|
|
| Selling, General & Administrative |
(46 683)
|
(42 957)
|
(28 361)
|
(29 814)
|
(16 643)
|
(11 360)
|
(20 200)
|
(19 105)
|
(17 297)
|
(21 853)
|
(23 465)
|
(24 341)
|
(26 180)
|
(27 585)
|
|
| Research & Development |
(15 935)
|
(16 081)
|
(16 138)
|
(17 548)
|
(15 967)
|
(15 563)
|
(13 405)
|
(13 064)
|
(13 121)
|
(13 149)
|
(13 577)
|
(14 008)
|
(13 742)
|
(15 693)
|
|
| Depreciation & Amortization |
(783)
|
(883)
|
(823)
|
(951)
|
(1 253)
|
(1 524)
|
(1 867)
|
(2 089)
|
(2 077)
|
(2 066)
|
(1 983)
|
(1 991)
|
(2 152)
|
(2 433)
|
|
| Other Operating Expenses |
(1)
|
(6)
|
0
|
(147 211)
|
(59)
|
(24 348)
|
0
|
(8 414)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
371 578
N/A
|
352 470
-5%
|
295 410
-16%
|
(69 282)
N/A
|
(37 003)
+47%
|
(85 324)
-131%
|
(47 041)
+45%
|
(51 259)
-9%
|
14 515
N/A
|
11 518
-21%
|
12 215
+6%
|
13 437
+10%
|
17 121
+27%
|
18 409
+8%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
375 658
|
346 258
|
253 517
|
109 621
|
(9 768)
|
(94 638)
|
(54 600)
|
(8 673)
|
11 034
|
(41 666)
|
45 917
|
27 378
|
100 554
|
102 379
|
|
| Non-Reccuring Items |
(114 169)
|
(131 380)
|
(147 264)
|
0
|
(41 503)
|
0
|
(8 409)
|
0
|
(18)
|
(18)
|
14 062
|
14 049
|
14 063
|
14 065
|
|
| Gain/Loss on Disposition of Assets |
(57)
|
13 421
|
13 419
|
13 417
|
13 389
|
267
|
271
|
(70)
|
197
|
(129)
|
64
|
416
|
351
|
(1 451)
|
|
| Total Other Income |
(262)
|
(291)
|
(304)
|
(66)
|
(124)
|
(131)
|
288
|
172
|
49
|
1 437
|
1 069
|
1 111
|
1 341
|
(2)
|
|
| Pre-Tax Income |
632 749
N/A
|
580 478
-8%
|
414 778
-29%
|
53 690
-87%
|
(75 009)
N/A
|
(179 825)
-140%
|
(109 491)
+39%
|
(59 830)
+45%
|
25 777
N/A
|
(28 857)
N/A
|
73 327
N/A
|
56 391
-23%
|
133 430
+137%
|
133 398
0%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(135 704)
|
(115 815)
|
(106 980)
|
(16 597)
|
6 037
|
23 851
|
88 994
|
79 003
|
55 874
|
69 212
|
(18 065)
|
(14 014)
|
(13 275)
|
(15 749)
|
|
| Income from Continuing Operations |
497 045
|
464 663
|
307 798
|
37 093
|
(68 973)
|
(155 974)
|
(20 497)
|
19 173
|
81 651
|
40 355
|
55 261
|
42 377
|
120 155
|
117 649
|
|
| Net Income (Common) |
497 045
N/A
|
464 663
-7%
|
307 798
-34%
|
37 093
-88%
|
(68 973)
N/A
|
(155 974)
-126%
|
(20 497)
+87%
|
19 173
N/A
|
81 651
+326%
|
40 355
-51%
|
55 261
+37%
|
42 377
-23%
|
120 155
+184%
|
117 649
-2%
|
|
| EPS (Diluted) |
4 878.92
N/A
|
4 561.06
-7%
|
3 021.3
-34%
|
364.09
-88%
|
-676.39
N/A
|
-1 529.08
-126%
|
-200.99
+87%
|
187.86
N/A
|
800.06
+326%
|
396.12
-50%
|
542
+37%
|
418.07
-23%
|
1 185.41
+184%
|
1 162.31
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
